Novel Prognostic and Therapeutic Mutations in Acute Myeloid Leukemia

Item

http://www.wikidata.org/entity/Q28075654

description

2016 nî lūn-bûn

@nan

2016 թուականին հրատարակուած գիտական յօդուած

@hyw

2016 թվականին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Novel Prognostic and Therapeutic Mutations in Acute Myeloid Leukemia

@ast

Novel Prognostic and Therapeutic Mutations in Acute Myeloid Leukemia

@en

Novel Prognostic and Therapeutic Mutations in Acute Myeloid Leukemia

@nl

type

Item

label

Novel Prognostic and Therapeutic Mutations in Acute Myeloid Leukemia

@ast

Novel Prognostic and Therapeutic Mutations in Acute Myeloid Leukemia

@en

Novel Prognostic and Therapeutic Mutations in Acute Myeloid Leukemia

@nl

prefLabel

Novel Prognostic and Therapeutic Mutations in Acute Myeloid Leukemia

@ast

Novel Prognostic and Therapeutic Mutations in Acute Myeloid Leukemia

@en

Novel Prognostic and Therapeutic Mutations in Acute Myeloid Leukemia

@nl

P1476

Novel Prognostic and Therapeutic Mutations in Acute Myeloid Leukemia

@en

P2093

Michael Medinger

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as sequence-specific DNA-binding proteins: the runt homology domain is required for DNA binding and protein-protein interactions

The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate

Acute Myeloid Leukemia: A Concise Review

Defining minimal residual disease in acute myeloid leukemia: which platforms are ready for "prime time"?

DNMT3A Mutations in Acute Myeloid Leukemia

Antileukemic activity of nuclear export inhibitors that spare normal hematopoietic cells

Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemia.

Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations.

Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype.

The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia.

P304

317-329

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Claudia Lengerke

Jakob R. Passweg

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27566651

http://www.w3.org/2001/XMLSchema#string

P921

leukemia

P932

5070622

http://www.w3.org/2001/XMLSchema#string